Electro-Mechanical Window Monitoring for Arrhythmia Risk

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for assessing the risk of cardiac arrhythmias in ambulatory subjects are challenging due to invasive procedures and noisy signal measurements, leading to inaccurate predictions and the false elimination of effective drugs from development pipelines.

Innovation Solution

A cardiac-based metric is computed by measuring the time difference between mechanical and electrical systoles using acoustical vibrations from the aortic valve closure and ECG signals, allowing for non-invasive and accurate characterization of cardiac function and arrhythmic risk, independent of heart rate.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If non-invasive sensing techniques are used to assess cardiac arrhythmia risk in ambulatory subjects, then ease of operation and patient comfort are improved, but measurement precision deteriorates due to noisy signals

Engineering Contradiction:
Improveease of assessmentVSAvoidsignal accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent combines multiple sensing modalities (acoustic sensors for heart sounds, ECG electrodes for electrical activity, and motion sensors) into an integrated assessment system. By merging these different signal sources, the system achieves reliable arrhythmia risk assessment in ambulatory subjects despite individual signal noise, as the combined electro-mechanical analysis provides complementary information that compensates for weaknesses in any single modality

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent introduces an intermediate processing layer that analyzes the relationship between electrical (ECG) and mechanical (heart sounds) signals. Rather than directly interpreting noisy individual signals, the system uses the time relationship between ECG complexes and subsequent heart sounds as an intermediary metric, which is more robust to noise and provides reliable arrhythmia risk assessment

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If invasive procedures are used to obtain accurate cardiac measurements, then measurement precision is improved, but device complexity and patient discomfort increase

Engineering Contradiction:
Improvesignal accuracyVSAvoidprocedure invasiveness
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces invasive mechanical measurement systems with non-invasive acoustic and electrical sensing. Instead of using catheters or implanted pressure sensors, the system uses external acoustic sensors to detect heart sounds and ECG electrodes to detect electrical activity, achieving sufficient measurement precision without invasive procedures or complex implanted devices

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Ease of operation

If traditional heart rate dependent risk indicators are used, then ease of measurement is improved, but reliability deteriorates due to interpretability difficulties

Engineering Contradiction:
Improvemeasurement simplicityVSAvoidrisk assessment accuracy
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent changes the assessment parameter from heart rate dependent metrics to electro-mechanical window (EMW) based metrics. The EMW, defined as the time interval between the ECG complex and the subsequent heart sound, provides a heart rate independent measure of arrhythmia risk. This parameter change maintains measurement simplicity while significantly improving reliability and interpretability of risk assessment

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables reliable and sensitive assessment of arrhythmic risk in ambulatory patients, improving predictive accuracy and reducing false positives in drug development, while providing a cost-effective and practical method for characterizing cardiac function.

Implementation Method 1

The end of a mechanical systole is identified, for each of a plurality of cardiac cycles of the subject, based upon an acoustical vibration associated with closure of an aortic valve during the cardiac cycle

Methodology Applied
Scientific EffectAcoustical vibration: Sound

Data Source

PatentUS9008762B2Method and apparatus for identifying cardiac risk
Publication Date: 2015.04.14 VIVAQUANT LLC
  • US9008762B2 patent drawing
  • US9008762B2 patent drawing
  • US9008762B2 patent drawing

AI summary

A cardiac-based metric is computed based upon characteristics of a subject's cardiac function. In accordance with one or more embodiments, the end of a mechanical systole is identified for each of a plurality of cardiac cycles of a subject, based upon an acoustical vibration associated with closure of an aortic valve during the cardiac cycle. The end of an electrical systole of an electrocardiogram (ECG) signal for each cardiac cycle is also identified. A cardiac-based metric is computed, based upon a time difference between the end of the electrical systole and the end of the mechanical systole, for the respective cardiac cycles.